Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
10,915,750
-
Number of holders
-
264
-
Total 13F shares, excl. options
-
10,915,798
-
Shares change
-
+393,230
-
Total reported value, excl. options
-
$2,418,264,368
-
Value change
-
+$107,291,483
-
Put/Call ratio
-
156%
-
Number of buys
-
126
-
Number of sells
-
-133
-
Price
-
$221.55
Significant Holders of MEDIFAST INC - Common Stock, $0.001 par value per share (MED) as of Q3 2018
310 filings reported holding MED - MEDIFAST INC - Common Stock, $0.001 par value per share as of Q3 2018.
MEDIFAST INC - Common Stock, $0.001 par value per share (MED) has 264 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,915,798 shares
.
Largest 10 shareholders include BlackRock Inc. (1,692,494 shares), Vanguard Group Inc (1,285,140 shares), RENAISSANCE TECHNOLOGIES LLC (958,400 shares), DIMENSIONAL FUND ADVISORS LP (686,014 shares), ACADIAN ASSET MANAGEMENT LLC (426,232 shares), STATE STREET CORP (391,343 shares), GOLDMAN SACHS GROUP INC (253,311 shares), ARROWSTREET CAPITAL, LIMITED PARTNERSHIP (231,522 shares), Bank of New York Mellon Corp (190,951 shares), and PRINCIPAL FINANCIAL GROUP INC (176,198 shares).
This table shows the top 264 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.